Alexander Golovin

Alexander Golovin

Auto-generated profile, based on publicly available information

Alexander Golovin

Joint-stock company "IMPULSE-project" Research and production company

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2020 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
МЖМ. О. Жульков
М. О. Жульков
АГА. М. Головин
А. М. Головин
ЕГЕ. О. Головина
Е. О. Головина
AGAlexander Grenadyorov
Alexander Grenadyorov
АФА. В. Фомичев
А. В. Фомичев
АCАлександр Михайлович Chernyavskiy
Александр Михайлович Chernyavskiy
Background. A shortage of donor organs is one of the urgent problems of transplantology. Despite the current level of technology, there are a number of difficult barriers to overcome. Because of the high demand for assisted circulatory devices, the work caused by the creation of the most physiological and biocompatible model of the apparatus, exceptional relevance is provided.Aim. To evaluate the haemolytic properties of the auxiliary circulatory apparatus based on a disk-type pump.Methods. A hydrodynamic bench was created to conduct haemolysis tests of a disk-type pump. The bench consisted of a tank, a heat exchanger, hydrodynamic resistance, connecting tubes, a blood sampling port, a pressure and flow measurement system, and a test pump. The test method consisted of assessing the level of free plasma haemoglobin (pHb) obtained by taking blood samples during pump operation in the operating mode (2300–2500 rpm, 5–6 l/min, pressure drop at the clamp level of 100 mmHg). Standardized haemolysis indices (NIH and MIH) were calculated based on the data obtained. The indices were calculated based on the analysis of free haemoglobin in the plasma of blood samples, haematocrit, total haemoglobin, blood flow, and pump operating time.Results. Bench tests (n = 5) revealed that the average level of free haemoglobin was 2.2 mg/%. This confirms the absolute atraumatic nature of the design of a new type of pump. The calculated values of the haemolysis indices were: NIH - 0.0013 and MIH - 1.88. This proves the fundamental possibility of using a disk-type pump as a basis for creating auxiliary circulatory devices.Conclusion. The developed methodology for assessing the mechanical stability of red blood cells allows you to give objective information about one of the most important safety criteria for auxiliary circulatory devices i.e., the level of haemolysis. The results obtained revealed that it is possible and safe to use a disk-type pump as an auxiliary circulatory device. Received 16 December 2019. Revised 10 March 2020. Accepted 13 March 2020. Funding: The research is supported by a grant of the Russian Science Foundation (project No. 19-19-00186). Conflict of interest: Authors declare no conflict of interest. Author contributions Conception and study design: M.O. ZhulkovData collection and analysis: M.O. Zhulkov, A.S. Grenadyorov, A.M. Golovin, E.O. Golovina, A.V. Fomichev, S.A. AlsovDrafting the article: M.O. Zhulkov, A.S. Grenadyorov Critical revision of the article: M.O. Zhulkov, A.M. ChernyavskiyFinal approval of the version to be published: M.O. Zhulkov, A.S. Grenadyorov, A.M. Golovin, E.O. Golovina, A.V. Fomichev, S.A. Alsov, A.M. Chernyavskiy

28 September 2020 in Journal of Experimental and Clinical Surgery
Verified
Journal Article
Open access
PDF file
MZMaksim Zhulkov
Maksim Zhulkov
AGAlexander Golovin
Alexander Golovin
AGAlexander Grenadyorov
Alexander Grenadyorov
VTVitaliy Tsirikhov
Vitaliy Tsirikhov
ASAzat Sabetov
Azat Sabetov
ЧМЧернявский Александр Михайлович
Чернявский Александр Михайлович
Introduction. Currently, the possibility of effective correction of multiple organ failure and increasing the life expectancy of patients with critical heart failure using the ventricular assist devices (VAD) is absolutely evidenced. The development of alternative analogues of such devices produced within the country has been an urgent problem for many decades. The design of this machine requires the development of a protocol for carrying out complex biomedical studies on the biocompatibility and safety of the new device.The aim of the study was to develop a protocol for testing and conducting comprehensive biomedical biocompatibility studies of a new ventricular assist device in an acute animal experiment.Materials and methods. The study to develop a technique for implanting a left-ventricular assist device (LVAD) in an acute experiment included female mini-pigs, weighed 40-60 kg. In a series of acute experiments, 5 implantations of a disk pump as a LVAD were performed with a maximum observation period equal 6 hours.Results. In the series of acute experiments, an implantation technique was developed and the fundamental possibility of a viscous friction pump application as a ventricular assist device was evidenced. In all experiments (n = 5), the average level of free hemoglobin did not exceed 2.6 mg%, which supports safety of performance of the viscous friction pump regarding blood erythrocytes. None of the experiments recorded episodes of pump shut-off or breakdown.Conclusions. The series of acute experiments on mini-pigs helped reveal a number of anatomical and physiological features of this animal species that significantly complicated implementation of persistent observation. However, the developed experimental LVAD test methodology can be recommended for use in further chronic experiments on large laboratory animals (calves).